Holen Sie sich die Stockscreener-App
2.28
0.00%
0.00
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -
Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - quiverquant.com
A nasal PTSD treatment met specs for nine months - Stock Titan
Silo Pharma Stock Price Forecast. Should You Buy SILO? - StockInvest.us
Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (SILO) Peer Comparison – Compare with Others - Value Research
Silo Pharma Inc (SILO) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Silo Pharma Acquires Digital Assets via Stock Issuance - The Globe and Mail
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa
Form 8K Silo Pharma Inc For: 19 August - Investing.com India
Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView
Silo Pharma Secures Canadian Patent Allowance for PTSD Treatment SPC-15 - citybuzz -
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - The Manila Times
Silo Pharma Receives Notice of Allowance for Canadian Patent Application Covering Lead Asset Spc-15 Targeting Ptsd and Other Stress-Induced Psychiatric Disorders - marketscreener.com
Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet
Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks
Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan
Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on February 23, 2026. - marketscreener.com
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times
Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative
SILO Q4 2023 Earnings: Wider-than-Expected Loss of -$5.40 per Share Highlights Heavy Pre-Revenue InvestmentTax Rate Impact - vinanet.vn
Silo Pharma Inc (SILO) Stock News Today - TradingKey
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Silo Pharma (SILO) Q4 2023 Earnings: Wider-Than-Expected Loss Sends Shares Down 20%Quarterly Earnings - vinanet.vn
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon - GlobeNewswire
SILO|Silo Pharma Inc|Price:3.200|Chg%:-0.020 - TradingKey
SILO Q4 2023 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D SpendingQuarterly Earnings Report - vinanet.vn
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - TradingView
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Silo Pharma Inc. Q4 2023 Earnings: Wider-Than-Expected Loss Weighs on SharesHigh Estimate Range - vinanet.vn
Silo Pharma Inc (SILO) Income Statement - TradingKey
SILO|Silo Pharma Inc|Price:4.470|Chg%:+0.010 - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com India
Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView
SILO Q4 2023 Earnings: Significant EPS Miss Highlights Operational ChallengesEarnings Volatility Report - vinanet.vn
Silo Pharma Advances AI Agent Platform Toward Commercial Launch And Progresses Lead PTSD Drug Program SPC-15 - marketscreener.com
Silo Pharma plans AI platform launch, advances PTSD drug program By Investing.com - Investing.com Canada
Silo Pharma Advances QwikAgents Commercial Launch and SPC-15 Development - Quiver Quantitative
Silo Pharma expects its PTSD nasal-spray study to finish in 60 days - Stock Titan
Silo Pharma to launch AI platform and advances PTSD drug SPC-15 with FDA steps ahead - Pluang
Silo Pharma raises $4 million in private placement By Investing.com - Investing.com Nigeria
Silo Pharma, Inc. (SILO) Stock: Slide 4.92% as QwikAgents Joins AMD AI Developer Program - CoinCentral
Silo Pharma (SILO) Q4 2023 Earnings: EPS Misses by Wide Margin, No Revenue Reported; Stock Gains 1.89%Forward Guidance Trends - vinanet.vn
Silo Pharma unit eyes faster AI agent development through AMD partnership - MSN
Silo Pharma Gains AI Spotlight After NVIDIA Partnership Enhances QwikAgents PlatformAdjusted Earnings Analysis - dars.gov.et
Silo Pharma (SILO) completes $4,000,015 private exempt securities sale - Stock Titan
Silo Pharma Advances AI Integration and PTSD Treatment Development - sekbernews.id
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):